NMRA analyst estimates
Neumora Therapeutics (NMRA) analyst ratings, the average price target and its range, and every firm's latest call.
- 6 firms rate NMRA: 6 buy, 0 hold, 0 sell.
- The average price target is $4.50 from None analysts, from $4.00 to $5.00.